IRIS
RAIMONDO, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.206
EU - Europa 13.304
AS - Asia 6.439
SA - Sud America 2.200
Continente sconosciuto - Info sul continente non disponibili 467
AF - Africa 223
OC - Oceania 19
Totale 36.858
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.778
RU - Federazione Russa 6.643
SG - Singapore 2.513
CN - Cina 2.008
BR - Brasile 1.884
IE - Irlanda 1.600
SE - Svezia 1.420
IT - Italia 1.021
HK - Hong Kong 687
DE - Germania 589
UA - Ucraina 411
FR - Francia 379
VN - Vietnam 363
FI - Finlandia 302
GB - Regno Unito 299
PL - Polonia 271
CA - Canada 186
IN - India 184
BD - Bangladesh 106
AR - Argentina 97
BE - Belgio 76
MX - Messico 71
TR - Turchia 70
ID - Indonesia 61
AT - Austria 59
ZA - Sudafrica 59
IQ - Iraq 56
EC - Ecuador 55
CO - Colombia 50
NL - Olanda 49
ES - Italia 46
JP - Giappone 44
PK - Pakistan 44
MA - Marocco 39
IL - Israele 37
UZ - Uzbekistan 37
CZ - Repubblica Ceca 32
VE - Venezuela 30
JM - Giamaica 29
CI - Costa d'Avorio 25
AE - Emirati Arabi Uniti 24
PY - Paraguay 23
CR - Costa Rica 22
CL - Cile 19
JO - Giordania 19
SA - Arabia Saudita 19
SV - El Salvador 19
KE - Kenya 18
LT - Lituania 18
AZ - Azerbaigian 17
PH - Filippine 17
HN - Honduras 16
SC - Seychelles 16
BO - Bolivia 15
NP - Nepal 15
TN - Tunisia 15
TT - Trinidad e Tobago 15
DZ - Algeria 14
KZ - Kazakistan 14
LB - Libano 14
PE - Perù 14
GT - Guatemala 13
IR - Iran 13
MY - Malesia 13
KG - Kirghizistan 12
UY - Uruguay 12
EE - Estonia 11
GR - Grecia 11
NZ - Nuova Zelanda 11
PR - Porto Rico 11
NI - Nicaragua 10
GP - Guadalupe 9
OM - Oman 9
AU - Australia 8
BG - Bulgaria 8
CW - ???statistics.table.value.countryCode.CW??? 8
DO - Repubblica Dominicana 8
EG - Egitto 8
PT - Portogallo 8
DK - Danimarca 7
BZ - Belize 6
ET - Etiopia 6
LV - Lettonia 6
AL - Albania 5
AM - Armenia 5
BY - Bielorussia 5
KW - Kuwait 5
NO - Norvegia 5
PS - Palestinian Territory 5
SN - Senegal 5
AO - Angola 4
KR - Corea 4
PA - Panama 4
RO - Romania 4
RS - Serbia 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
BN - Brunei Darussalam 3
CH - Svizzera 3
EU - Europa 3
Totale 36.353
Salva come PNG Salva come JPEG
Città #
Ashburn 2.591
Moscow 2.022
Dublin 1.599
Singapore 1.458
Dallas 1.359
Chandler 1.074
San Jose 889
Jacksonville 839
Nyköping 837
Beijing 686
Hong Kong 684
Council Bluffs 444
Messina 414
The Dalles 338
Los Angeles 288
Ann Arbor 253
Warsaw 250
Princeton 247
Medford 224
Lauterbourg 216
Cambridge 188
Des Moines 181
Munich 167
New York 160
São Paulo 159
Dearborn 145
Ho Chi Minh City 130
Boardman 118
Santa Clara 108
Buffalo 99
Houston 89
Phoenix 85
Woodbridge 85
Wilmington 81
Jinan 74
Tianjin 74
Brussels 72
Frankfurt am Main 72
Hanoi 69
Orem 67
Redondo Beach 66
Helsinki 62
Brasília 61
Guangzhou 59
Rio de Janeiro 58
Rome 58
San Mateo 58
Nanjing 54
Shenyang 54
Belo Horizonte 53
Chicago 51
North Bergen 51
Turku 50
Brooklyn 49
Seattle 48
Atlanta 45
Chennai 43
Tokyo 42
Columbus 40
Montreal 40
Nuremberg 40
Hebei 38
Vienna 38
Falls Church 37
Pune 36
Shanghai 36
Haikou 35
Denver 34
San Francisco 33
Shenzhen 32
Zhengzhou 32
Milan 31
Tashkent 31
Catania 30
Jakarta 30
Stockholm 30
Hyderabad 28
Porto Alegre 28
Amsterdam 26
Baghdad 26
Curitiba 26
Abidjan 25
Boston 25
Bremen 25
Lancaster 25
Johannesburg 24
London 23
Brno 22
Dong Ket 22
Mexico City 22
Ottawa 22
Guarulhos 21
Manchester 21
Toronto 21
Campinas 20
Hangzhou 20
Nanchang 20
Ningbo 20
Quito 20
Mumbai 19
Totale 21.071
Salva come PNG Salva come JPEG
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 397
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 345
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 285
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 283
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 279
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 278
Atrial fibrillation in patients with cirrhosis 275
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 252
Hepatitis B virus (HBV) markers and HBV-DNA in serum and liver tissue of patients with acute exacerbation of chronic type B hepatitis 241
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 238
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 235
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 234
HBE ANTIBODY UNRELATED TO E-MINUS HEPATITIS-B VIRUS VARIANT INFECTION IN PATIENTS WITH CHRONIC TYPE-D HEPATITIS 227
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 227
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 227
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 226
Risk Factors Associated with NASH in Obese Patients Undergoing Bariatric Surgery NASH and bariatric surgery 226
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 226
A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation 226
Does the margin width influence recurrence rate in liver surgery for hepatocellular carcinoma smaller than 5 cm? 225
Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease? 222
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 222
Erectile dysfunction in compensated liver cirrhosis 221
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 219
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 217
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 216
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta virus superinfection. 213
An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers 212
A GENETIC-POLYMORPHISM OF THE APOLIPOPROTEIN AI-CIII GENE- CLUSTER IS ASSOCIATED WITH CORONARY HEART-DISEASE IN NON- INSULIN-DEPENDENT DIABETES-MELLITUS 209
Control of cccDNA function in hepatitis B virus infection. 209
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 209
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. 208
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 208
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 207
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 205
HEPATITIS-B VIRUS VARIANT, WITH A DELETION IN THE PRES2 AND 2 TRANSLATIONAL STOP CODONS IN THE PRECORE REGIONS, IN A PATIENT WITH HEPATOCELLULAR-CARCINOMA 204
Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease. 202
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 201
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy 200
Analysis of HBV integration in mitochondrial DNA of HepAD38 cells by the high-throughput HBV integration sequencing and RNASeq approaches 198
Exacerbation of chronic liver disease due to hepatitis B surface antigen after delta infection. 196
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 196
ALFA-INTERFERON TREATMENT INDUCES INSULIN AUTOANTIBODIES IN PATIENTS WITH CHRONIC VIRAL-HEPATITIS 195
Mitochondrial DNA is a target of HBV integration 192
[A glance into the past ... Southern and northern blot: really superseded?] 190
Cirrhosis related to wild-type HBV infection in siblings with A3 - B35 - Cw4 HLA class I phenotype. 190
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 189
A 2010 update on occult hepatitis B infection. 187
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 184
Human hepatitis B virus negatively impacts the protective immune cross-talk between natural killer and dendritic cells 183
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 183
Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection 182
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 181
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 180
Evaluation of liver enzyme levels and identification of asymptomatic liver disease patients in primary care 180
Clinical virology of hepatitis B virus infection 178
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 178
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 177
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 177
A NEW HEPATITIS-B VIRUS VARIANT IN A CHRONIC CARRIER WITH MULTIPLE EPISODES OF VIRAL REACTIVATION AND ACUTE HEPATITIS 176
Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. 176
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 175
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 173
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 173
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 172
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 172
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 172
Correlates of total homocysteine plasma concentration in type 2 diabetes 171
Low prevalence of hepatitis B and hepatitis C virus serum markers in a cohort of pregnant women from Southern Italy 171
Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts. 169
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 168
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 167
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 167
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 167
Monofocal hepatocellular carcinoma: How much does size matter? 166
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 165
Disease progression and liver cancer in the ferroportin disease. 165
Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma 164
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta superinfection. 163
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 163
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 (IL8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY 162
Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. 162
Obesity and liver cancer 162
BILE DUCTOPENIA FOLLOWING THERAPY WITH SULPIRIDE 161
Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre study 161
HISTOLOGICAL BEHAVIOR OF CHRONIC HEPATITIS IN PATIENTS TREATED WITH ALPHA-INTERFERON 161
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 161
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis 160
ABNORMAL ALANINE AMINOTRANSFERASE ACTIVITY REFLECTS EXPOSURE TO HEPATITIS-C VIRUS IN HEMODIALYSIS-PATIENTS 160
Effectiveness of add-on Pegylated interferon alfa-2a therapy in a Lamivudine-treated patient with chronic hepatitis B 160
High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. 159
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents. 159
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 158
Pattern of macrovascular invasion in hepatocellular carcinoma 157
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. 156
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 156
The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. 156
Update of the statements on biology and clinical impact of occult hepatitis B virus infection 156
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 153
Seroprevalence of hepatitis B virus and hepatitis C virus infections in elderly residents in nursing homes in Southern Italy 153
Totale 19.600
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.716
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.716
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.360 0 0 0 0 95 33 126 59 29 281 216 521
2022/20234.528 334 464 224 320 309 451 81 246 1.896 31 134 38
2023/20241.189 81 180 54 104 100 197 19 248 6 56 34 110
2024/20255.245 78 75 139 347 274 221 209 1.054 1.232 309 460 847
2025/202616.412 718 1.237 1.211 1.097 1.285 3.393 2.031 1.964 2.047 731 302 396
2026/20273.272 480 594 858 1.197 143 0 0 0 0 0 0 0
Totale 36.858